Published in Front Aging Neurosci on September 19, 2014
Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol (2015) 1.75
Glymphatic solute transport does not require bulk flow. Sci Rep (2016) 0.93
Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases. Cell Mol Neurobiol (2016) 0.88
Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis. PLoS One (2015) 0.85
4D flow MRI for intracranial hemodynamics assessment in Alzheimer's disease. J Cereb Blood Flow Metab (2015) 0.83
How astrocyte networks may contribute to cerebral metabolite clearance. Sci Rep (2015) 0.83
Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol (2016) 0.82
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta (2015) 0.82
In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein. Front Aging Neurosci (2016) 0.80
A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer's disease. J Neural Transm (Vienna) (2015) 0.79
Mechanisms of Aβ Clearance and Degradation by Glial Cells. Front Aging Neurosci (2016) 0.79
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. Cell Mol Neurobiol (2015) 0.78
Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions. J Alzheimers Dis (2015) 0.77
Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1-40-induced toxicity. Acta Pharm Sin B (2015) 0.76
Increased Aβ pathology in aged Tg2576 mice born to mothers fed a high fat diet. Sci Rep (2016) 0.76
Effect of a water-maze procedure on the redox mechanisms in brain parts of aged rats. Front Aging Neurosci (2015) 0.75
Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Front Neurosci (2016) 0.75
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol Commun (2017) 0.75
Age-related Impairment of Vascular Structure and Functions. Aging Dis (2017) 0.75
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease. Int J Mol Sci (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron (2008) 10.19
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A (1986) 10.13
Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer (2003) 6.65
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Survival after initial diagnosis of Alzheimer disease. Ann Intern Med (2004) 5.52
Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron (2010) 5.20
Cerebral amyloid angiopathy. A critical review. Stroke (1987) 4.56
Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol (2004) 4.22
Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging (2000) 4.22
Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science (2002) 3.93
A simplified laminin nomenclature. Matrix Biol (2005) 3.81
Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol (2001) 3.49
Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett (1986) 3.36
Molecular architecture of basement membranes. FASEB J (1990) 3.28
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int (2004) 3.16
Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci (2004) 3.09
Supramolecular assembly of basement membranes. Bioessays (1996) 2.97
The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry (1998) 2.91
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Macromolecular organization of basement membranes. Curr Opin Cell Biol (1996) 2.72
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol (2006) 2.71
Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation (2004) 2.67
Mammalian collagen IV. Microsc Res Tech (2008) 2.56
Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna) (2002) 2.55
Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev (2005) 2.46
Human amyloidosis, Alzheimer disease and related disorders. Lab Invest (1988) 2.44
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain (2008) 2.34
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32
The impact of the extracellular matrix on inflammation. Nat Rev Immunol (2010) 2.30
The genetics of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.20
Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res (2010) 2.07
Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol (2001) 1.98
Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension (2012) 1.96
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol (1998) 1.92
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Renal basement membrane components. Kidney Int (1999) 1.83
Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol (2002) 1.81
Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med (2003) 1.79
Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res (2005) 1.76
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am J Pathol (2006) 1.73
The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol (1982) 1.68
Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology (1982) 1.64
Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol (1981) 1.62
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol (2005) 1.61
Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol (2005) 1.59
Drainage of interstitial fluid from different regions of rat brain. Am J Physiol (1984) 1.58
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther (1996) 1.53
Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Neurology (2009) 1.41
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol (2011) 1.41
Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol (2005) 1.40
Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol (2000) 1.39
Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem (1997) 1.34
Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging (2001) 1.34
Biomechanical properties of native basement membranes. FEBS J (2007) 1.31
Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol (1992) 1.31
Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol (1996) 1.26
Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry (2006) 1.25
Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol (2013) 1.24
High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol (1994) 1.24
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging (1990) 1.22
Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele. PLoS One (2012) 1.22
Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci (2000) 1.21
Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol (2006) 1.21
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol (2013) 1.15
Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev (1997) 1.14
Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) (1999) 1.14
Laminin isoforms in endothelial and perivascular basement membranes. Cell Adh Migr (2012) 1.13
Ultrastructural and biochemical analyses of isolated basement membranes from kidney glomeruli and tubules and brain and retinal microvessels. J Ultrastruct Res (1978) 1.11
Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med (2009) 1.10
Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol (2001) 1.08
Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging (2000) 1.08
Laminin alpha 2 is a component of brain capillary basement membrane: reduced expression in dystrophic dy mice. Neuroscience (1996) 1.06
Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J Am Geriatr Soc (2004) 1.06
Protein composition and biomechanical properties of in vivo-derived basement membranes. Cell Adh Migr (2012) 1.02
Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev Dyn (1997) 1.02
Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem (1990) 1.00
Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-β from the mouse brain. Aging Cell (2013) 0.99
Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (1994) 0.98
Expression of s-laminin and laminin in the developing rat central nervous system. J Comp Neurol (1992) 0.98
Fluid mechanics in the perivascular space. J Theor Biol (2011) 0.98
Scaffold-forming and Adhesive Contributions of Synthetic Laminin-binding Proteins to Basement Membrane Assembly. J Biol Chem (2009) 0.97
Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol (2006) 0.96
Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med (2009) 0.95
Laminins: a family of diverse multifunctional molecules of basement membranes. J Invest Dermatol (1996) 0.93
Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction. J Neurosci (2010) 0.91
Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int (1993) 0.91
Laminin-like antigen in rat CNS neurons: distribution and changes upon brain injury and nerve growth factor treatment. Neuron (1989) 0.91
Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol (1995) 0.89
Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol Aging (1992) 0.88
Review. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol (1996) 0.88
Laminins in the adult and aged brain. Mol Chem Neuropathol (1997) 0.88
The extracellular matrix in neural crest-cell migration. Trends Neurosci (1997) 0.87
Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int J Dev Neurosci (2009) 0.86